LegalJul 20, 2026, 05:31 PM
NeoGenomics Settles DOJ Investigation for $9.8M
AI Summary
NeoGenomics, Inc. announced a civil settlement with the U.S. Department of Justice (DOJ) on behalf of the Office of Inspector General of the U.S. Department of Health and Human Services (OIG-HHS). The settlement resolves an investigation into the company's consulting services provided to healthcare providers, which NeoGenomics had voluntarily self-disclosed in November 2021. The company agreed to pay $9,813,260 plus interest, which is less than the $11.2 million reserve previously accrued for the matter. CEO Tony Zook expressed satisfaction with resolving this legacy issue.
Key Highlights
- Settled civil investigation with the U.S. Department of Justice (DOJ) and OIG-HHS.
- Agreed to pay $9,813,260 plus 4.250% interest from January 16, 2026.
- Payment resolves investigation into consulting services to healthcare providers.
- Previously accrued a reserve of $11.2 million for potential liabilities.
- Company voluntarily self-disclosed the matter to OIG-HHS in November 2021.
- Settlement is not an admission of liability by NeoGenomics.
Price Impact
More from NEO